The success in clinical studies, where anti-PD-1 agents reduced the remote metastasis of melanoma cells or colon cancer cells, improved the knowledge of PD-1/PD-L1 as an important anticancer target in human beings8. Here, PDCD1 is linked to colonic neoplasm.